---
title: "Vyleesi Carton Cost Compared to Addyi | HealthRX.com"
description: "Vyleesi runs about $850 to $950 per carton. Compare that with Addyi's once nightly 100 mg tablet and how many Vyleesi doses the label allows each month."
url: https://healthrx.com/bremelanotide/cost-vs-alternatives
publisher: HealthRX.com
---


HealthRX.com quick answer. Vyleesi is used as needed: its label says not to give more than one dose in 24 hours and that more than 8 doses a month is not recommended [1]. Addyi (flibanserin), an FDA-approved oral HSDD medicine, is a 100 mg tablet taken once a day at bedtime [3]. This page compares how much medicine each label directs, not what either costs.

At a glance

- Approved product / Vyleesi 1.75 mg subcutaneous autoinjector [1]
- Approved use / Premenopausal women with acquired, generalized HSDD [1]
- Dosing / As needed, at least 45 minutes before sexual activity [1]
- Dose limits / Not more than one dose in 24 hours; more than 8 doses a month is not recommended [1]
- Typical trial use / Two to three times a month, no more than once a week [1]
- Vyleesi boxed warning / None [1]
- Addyi dose / 100 mg by mouth once a day at bedtime [3]
- Addyi boxed warning / Yes: hypotension and syncope in certain settings [3]
- Compounded or research-use PT-141 / Not Vyleesi and not FDA-approved [2][1]

## What the label fixes about monthly use

Vyleesi is a single-strength product: 1.75 mg of [bremelanotide](https://healthrx.com/products/pt-141-rx) in a prefilled autoinjector, injected under the skin of the abdomen or thigh [1]. The label directs as-needed use at least 45 minutes before anticipated sexual activity and says not to give more than one dose within 24 hours [1]. More than 8 doses per month is not recommended; the label notes that more frequent dosing raises the risk of focal hyperpigmentation and lengthens the time each month when blood pressure is increased [1].

## How often Vyleesi is used

Vyleesi is taken as needed rather than on a daily schedule. In the two 24-week phase 3 trials, most patients used Vyleesi two to three times a month and no more than once a week [1]. The label also says the duration of effect after a dose is unknown and the best timing window has not been fully characterized [1].

## Why patients stopped Vyleesi in the trials

In the pooled phase 3 trials, 18% of Vyleesi patients stopped because of adverse reactions versus 2% on placebo [1]. Nausea was reported by 40.0% of Vyleesi patients versus 1.3% on placebo; 13% received anti-nausea medicine and 8% stopped the trials because of nausea [1]. Nausea was most common after the first dose, reported by 21% of patients, and fell to about 3% after later doses [1].

## How Addyi's label directs use

The Addyi label directs 100 mg by mouth once a day at bedtime; after a missed dose, the next dose is taken at bedtime the following day, not doubled [3]. Like Vyleesi's label, it says to discontinue after 8 weeks if the patient does not report improvement in HSDD symptoms [3]. Addyi's label has a boxed warning titled hypotension and syncope in certain settings. It includes an alcohol instruction (wait at least two hours after one or two standard drinks before the bedtime dose, and skip the dose after three or more) and lists moderate or strong CYP3A4 inhibitors and [hepatic impairment](https://healthrx.com/bremelanotide/hepatic-impairment) as contraindicated [3]. Vyleesi has no boxed warning [1].

## PT-141 sold as a peptide is not Vyleesi

'PT-141' products sold as compounded or research-use peptides are not Vyleesi and are not FDA-approved drugs [2][1]. Compounded drugs are not reviewed by FDA for safety, effectiveness or quality before marketing [2][1].

Frequently asked questions

How is Vyleesi dosed?

Vyleesi is 1.75 mg injected subcutaneously in the abdomen or thigh as needed, at least 45 minutes before sexual activity, with no more than one dose in 24 hours and no more than 8 doses a month recommended [1].

How often did trial patients use Vyleesi?

In the two 24-week phase 3 trials, most patients used Vyleesi two to three times a month and no more than once a week [1].

Why do people stop using Vyleesi?

In the pooled phase 3 trials, 18% of Vyleesi patients stopped for adverse reactions versus 2% on placebo; nausea was reported by 40.0% versus 1.3% on placebo, and 8% stopped because of nausea [1].

Is compounded PT-141 the same as Vyleesi?

No. Compounded and research-use PT-141 products are not Vyleesi and are not FDA-approved drugs, and compounded drugs are not reviewed by FDA for safety, effectiveness or quality before marketing [2][1].

How does Addyi dosing differ from Vyleesi?

Addyi is 100 mg by mouth once a day at bedtime [3]. Vyleesi is 1.75 mg injected as needed, with no more than one dose in 24 hours and more than 8 doses a month not recommended [1].

References

Show all 3 references Hide references

1. U.S. National Library of Medicine, DailyMed. Vyleesi ([bremelanotide](https://healthrx.com/pt-141)) injection, 1.75 mg subcutaneous autoinjector prescribing information. [Vyleesi (bremelanotide) injection, 1.75 mg subcutaneous autoinjector label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf)
2. Federal Register. Public inspection document 2026-22192. 2026. [Federal Register public inspection document 2026-22192](https://public-inspection.federalregister.gov/2026-22192.pdf)
3. U.S. Food and Drug Administration. Addyi (flibanserin) tablets prescribing information, openFDA drug label. [Addyi (flibanserin) prescribing information (openFDA)](https://api.fda.gov/drug/label.json?search=openfda.brand_name:ADDYI&limit=1)

Next in this cluster

Related reading

- [bremelanotide Vyleesi cost](https://healthrx.com/reviews-bremelanotide/cost-reports)
- [bremelanotide Vyleesi Storage, Stability & Shelf Life](https://healthrx.com/bremelanotide/storage-stability)
- [bremelanotide Compounded bremelanotide](https://healthrx.com/access-bremelanotide/compounded-equivalent)
- [bremelanotide Vyleesi patient assistance](https://healthrx.com/access-bremelanotide/patient-assistance)
- [bremelanotide Bremelanotide drug interactions](https://healthrx.com/bremelanotide/drug-drug-interactions)
- [bremelanotide Vyleesi geriatric dosing](https://healthrx.com/bremelanotide/geriatric-dosing)
- [bremelanotide Vyleesi dosing in hepatic impairment](https://healthrx.com/bremelanotide/hepatic-impairment)
- [bremelanotide Bremelanotide history](https://healthrx.com/bremelanotide/history-development)
- [bremelanotide Vyleesi humana prior authorization](https://healthrx.com/bremelanotide/humana-coverage)
- [bremelanotide Bremelanotide mechanism of action](https://healthrx.com/bremelanotide/mechanism-deep-dive)
- [bremelanotide Bremelanotide missed dose protocol](https://healthrx.com/bremelanotide/missed-dose-protocol)
- [bremelanotide Vyleesi older adult](https://healthrx.com/bremelanotide/older-adult-safety)
- [bremelanotide Vyleesi Side Effects, Withdrawal, and Discontinuation Syndrome](https://healthrx.com/side-effects-v2-bremelanotide/withdrawal-syndrome)
- [bremelanotide Vyleesi South Asian efficacy](https://healthrx.com/ethnicity-bremelanotide/south-asian--efficacy-differences)

![vyleesi cost vs alternatives: woman comparing monthly expenses with a calculator at a kitchen table](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/bremelanotide/cost-vs-alternatives.webp)

Comparing per-carton pricing with a nightly tablet helps patients budget before committing to either treatment. Full vyleesi cost guide and sources at [healthrx.com/bremelanotide](https://healthrx.com/bremelanotide).

Follow the ingredient research

Explore the publication history, study comparisons and formulations for Bremelanotide / PT-141.

- [Bremelanotide / PT-141 research](https://healthrx.com/research/ingredients/bremelanotide)

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
